PLI New York Center,
810 Seventh Avenue at 53rd Street (21st floor),
New York, New York 10019
October 29-30, 2012
Why you should attend
Over-the-counter (OTC) derivatives are key elements in many of our financial markets. The Dodd-Frank Act is substantially changing how these important instruments are regulated and transacted. This program will introduce you to both the instruments and their new environment.
A derivative is a financial instrument that allocates the risks and price exposures associated with a designated reference asset or entity between the parties thereto. Derivatives can provide price exposure or price insulation to changes in the price or level of an open-ended range of assets or baskets of assets, including indices, stocks, interest rates, currencies, bonds, commodities, insured risks, credit risks, investment funds, property, the weather and more. Derivatives are used in an infinite variety of ways by commercial, charitable, educational and governmental entities to manage the commercial and financial risks they confront. OTC derivatives have been bilaterally traded for many years. They are now becoming subject, in some cases, to required clearing and possible exchange-type trading. An understanding of the characteristics, documentation and regulation of these instruments is the first step to effective lawyering.
At this program, our distinguished faculty will explain what OTC derivatives have been, what they are becoming and how they are documented. The faculty will also provide an overview of the new regulatory framework for OTC derivatives and OTC derivatives market participants and explain how the new regulatory framework will affect these markets and market participants.
What you will learn
- What are OTC derivatives?
- What are the basic features of fixed income, credit, equity and commodity swaps?
- How are derivatives commonly traded today?
- What changes in trading methods are coming?
- What is the ISDA Master Agreement and how does it work?
- What additional documentation is appearing in response to market changes?
- How will OTC derivatives be regulated?
Partner Joshua Cohn will serve as co-chair, moderator and panelist; David Sahr will speak on an afternoon panel titled, “Financial Reform Overview.
For more information and to register, please click here.